NCT06107647

Brief Summary

Unintentional perioperative hypothermia is a common occurrence. One of the recommendations of the guidelines to prevent hypothermia is the use of active warmers. It is known that low-flow anesthesia protects from hypothermia compared to high-flow anesthesia. In this study, we aimed to compare the efficacy of using active air blown heater and resistive heater in preventing hypothermia in patients with low flow and high flow inhalation anesthesia

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 17, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 30, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
Last Updated

October 31, 2023

Status Verified

October 1, 2023

Enrollment Period

7 months

First QC Date

August 17, 2023

Last Update Submit

October 27, 2023

Conditions

Keywords

High flowhypothermialow flowrhinoplasty

Outcome Measures

Primary Outcomes (1)

  • Measurement of body temperatures in patients using two different body heaters during anesthesia applications.

    In our study, two patient groups receiving high current and low current anesthesia will be heated with only one type of heater, either active air blowing heater or resistive heater, from the beginning of anesthesia. Their body temperatures will be measured and recorded throughout the operation. In our study, COVIDIEN WarmTouch will be used as an active air blowing heater. INDITHERM Medical Alpha will be used as a resistive-type heater. Throughout the entire operation, body temperature will be monitored using the zero-heat flow method from the temporal artery to the body surface (3M Spot ON).

    6 mounth

Study Arms (4)

GRUP DA

EXPERIMENTAL

Patients who will be given low-flow anesthesia during the operation and will be heated with an active air blower heater.

Device: COVIDIEN WarmTouch

GRUP YA

EXPERIMENTAL

Patients who will be given high current anesthesia during the operation and will be heated with an active air blower heater.

Device: COVIDIEN WarmTouch

GRUP DR

EXPERIMENTAL

Patients who will be given low-flow anesthesia during the operation and will be heated with a resistive heater

Device: COVIDIEN WarmTouch

GRUP YR

EXPERIMENTAL

Patients who will be treated with high-flow anesthesia and heated with a resistive heater during the operation

Device: COVIDIEN WarmTouch

Interventions

"COVIDIEN WarmTouch will be used as an active air blowing heater. Patients will be warmed starting from the beginning of anesthesia." "The INDITHERM Medical Alpha, which is a resistive heater, will be applied to patients starting at the beginning of anesthesia."

Also known as: INDITHERM Medical Alpha
GRUP DAGRUP DRGRUP YAGRUP YR

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients between the ages of 18-65, who are included in the ASA I-III group, who will undergo rhinoplasty.

You may not qualify if:

  • Patients with BMI \> 35 KG/M²
  • Patients with body temperature \>37.5°C, \<36°C degrees
  • Those with cardiovascular system or central nervous system disease
  • Patients with thyroid disorders
  • Patients with autonomic dysfunction
  • Patients not between the ages of 18-65
  • Patients with missing information in the information form
  • Patients using steroids or vasoactive drugs.
  • Patients whose operation time is less than 30 minutes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Abdullah Pabucci

Istanbul, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Hypothermia

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • abdullah pabucci

    fatih sultan mehmet research and traning hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

abdullah md pabucci

CONTACT

arzu md yıldırım ar

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Doctor

Study Record Dates

First Submitted

August 17, 2023

First Posted

October 30, 2023

Study Start

June 1, 2023

Primary Completion

January 1, 2024

Study Completion

March 1, 2024

Last Updated

October 31, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations